111 related articles for article (PubMed ID: 9712349)
1. Binding affinity independent contribution of peptide length to the stability of peptide-HLA-DR complexes in live antigen presenting cells.
Siklodi B; Vogt AB; Kropshofer H; Falcioni F; Molina M; Bolin DR; Campbell R; Hämmerling GJ; Nagy ZA
Hum Immunol; 1998 Aug; 59(8):463-71. PubMed ID: 9712349
[TBL] [Abstract][Full Text] [Related]
2. Identification of the lateral interaction surfaces of human histocompatibility leukocyte antigen (HLA)-DM with HLA-DR1 by formation of tethered complexes that present enhanced HLA-DM catalysis.
Stratikos E; Mosyak L; Zaller DM; Wiley DC
J Exp Med; 2002 Jul; 196(2):173-83. PubMed ID: 12119342
[TBL] [Abstract][Full Text] [Related]
3. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
4. Disruption of hydrogen bonds between major histocompatibility complex class II and the peptide N-terminus is not sufficient to form a human leukocyte antigen-DM receptive state of major histocompatibility complex class II.
Schulze MS; Anders AK; Sethi DK; Call MJ
PLoS One; 2013; 8(7):e69228. PubMed ID: 23976922
[TBL] [Abstract][Full Text] [Related]
5. Short peptide sequences mimic HLA-DM functions.
Chou CL; Mirshahidi S; Su KW; Kim A; Narayan K; Khoruzhenko S; Xu M; Sadegh-Nasseri S
Mol Immunol; 2008 Apr; 45(7):1935-43. PubMed ID: 18054387
[TBL] [Abstract][Full Text] [Related]
6. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM.
Vogt AB; Kropshofer H; Moldenhauer G; Hämmerling GJ
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9724-9. PubMed ID: 8790398
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
Rosloniec EF; Whittington KB; Zaller DM; Kang AH
J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
[TBL] [Abstract][Full Text] [Related]
8. N-terminal elongation of a peptide determinant beyond the first primary anchor improves binding to H-2 I-Ad and HLA-DR1 by backbone-dependent and aromatic side chain-dependent interactions, respectively.
Bartnes K; Leon F; Briand JP; Travers PJ; Hannestad K
Eur J Immunol; 1999 Jan; 29(1):189-95. PubMed ID: 9933100
[TBL] [Abstract][Full Text] [Related]
9. Presentation of influenza hemagglutinin peptide in the presence of limited allostimulation by HLA-DR1 transfected human fibroblasts.
Eckels DD; Sell TW; Long EO; Sekaly RP
Hum Immunol; 1988 Mar; 21(3):173-81. PubMed ID: 2453491
[TBL] [Abstract][Full Text] [Related]
10. Human monoclonal antibody with T-cell-like specificity recognizes MHC class I self-peptide presented by HLA-DR1 on activated cells.
Wölpl A; Halder T; Kalbacher H; Neumeyer H; Siemoneit K; Goldmann SF; Eiermann TH
Tissue Antigens; 1998 Mar; 51(3):258-69. PubMed ID: 9550326
[TBL] [Abstract][Full Text] [Related]
11. Exploration of the P6/P7 region of the peptide-binding site of the human class II major histocompatability complex protein HLA-DR1.
Zavala-Ruiz Z; Sundberg EJ; Stone JD; DeOliveira DB; Chan IC; Svendsen J; Mariuzza RA; Stern LJ
J Biol Chem; 2003 Nov; 278(45):44904-12. PubMed ID: 12952957
[TBL] [Abstract][Full Text] [Related]
12. Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif.
Kropshofer H; Max H; Müller CA; Hesse F; Stevanovic S; Jung G; Kalbacher H
J Exp Med; 1992 Jun; 175(6):1799-803. PubMed ID: 1375272
[TBL] [Abstract][Full Text] [Related]
13. The Thermodynamic Mechanism of Peptide-MHC Class II Complex Formation Is a Determinant of Susceptibility to HLA-DM.
Ferrante A; Templeton M; Hoffman M; Castellini MJ
J Immunol; 2015 Aug; 195(3):1251-61. PubMed ID: 26116504
[TBL] [Abstract][Full Text] [Related]
14. The N-terminal region of photocleavable peptides that bind HLA-DR1 determines the kinetics of fragment release.
Negroni MP; Stern LJ
PLoS One; 2018; 13(7):e0199704. PubMed ID: 29965980
[TBL] [Abstract][Full Text] [Related]
15. Studies on activities of invariant chain peptides on releasing or exchanging of antigenic peptides at human leukocyte antigen-DR1.
Xu M; Jackson R; Adams S; Humphreys RE
Arzneimittelforschung; 1999 Sep; 49(9):791-9. PubMed ID: 10514908
[TBL] [Abstract][Full Text] [Related]
16. An insulin peptide that binds an alternative site in class II major histocompatibility complex.
Tompkins SM; Moore JC; Jensen PE
J Exp Med; 1996 Mar; 183(3):857-66. PubMed ID: 8642290
[TBL] [Abstract][Full Text] [Related]
17. Sodium dodecyl sulfate stability of HLA-DR1 complexes correlates with burial of hydrophobic residues in pocket 1.
Natarajan SK; Stern LJ; Sadegh-Nasseri S
J Immunol; 1999 Mar; 162(6):3463-70. PubMed ID: 10092802
[TBL] [Abstract][Full Text] [Related]
18. HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation.
Poluektov YO; Kim A; Hartman IZ; Sadegh-Nasseri S
PLoS One; 2013; 8(8):e71228. PubMed ID: 23951115
[TBL] [Abstract][Full Text] [Related]
19. HIV gp120 plus specific peptides are recognized in a similar manner to specific HLA plus peptide by HLA-restricted antigen-specific T-cell lines.
Sheikh J; Souberbielle B; Westby M; Austen B; Dalgleish AG
Viral Immunol; 2000; 13(1):9-17. PubMed ID: 10733164
[TBL] [Abstract][Full Text] [Related]
20. Identification of destabilizing residues in HLA class II-selected bacteriophage display libraries edited by HLA-DM.
Raddrizzani L; Bono E; Vogt AB; Kropshofer H; Gallazzi F; Sturniolo T; Hämmerling GJ; Sinigaglia F; Hammer J
Eur J Immunol; 1999 Feb; 29(2):660-8. PubMed ID: 10064083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
